| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/32853599_HAS_TOPIC_C0008115> <https://research.tib.eu/covid-19/entity/32853599_HAS_TOPIC_C0020966> <https://research.tib.eu/covid-19/entity/32853599_HAS_TOPIC_C0021515> <https://research.tib.eu/covid-19/entity/32853599_HAS_TOPIC_C0024683> <https://research.tib.eu/covid-19/entity/32853599_HAS_TOPIC_C0033522> <https://research.tib.eu/covid-19/entity/32853599_HAS_TOPIC_C0035363> <https://research.tib.eu/covid-19/entity/32853599_HAS_TOPIC_C0036859> <https://research.tib.eu/covid-19/entity/32853599_HAS_TOPIC_C0037186> <https://research.tib.eu/covid-19/entity/32853599_HAS_TOPIC_C0039194> <https://research.tib.eu/covid-19/entity/32853599_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/32853599_HAS_TOPIC_C0521117> <https://research.tib.eu/covid-19/entity/32853599_HAS_TOPIC_C1817908> <https://research.tib.eu/covid-19/entity/32853599_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/32853599_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/32853599_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'Department of Medical Oncology, Biotechnology and Immuno-Oncology Platform, University Hospital of Besançon, F-25000 Besançon, France; Department of Pharmacy, University Hospital of Besançon, F-25000 Besançon, France; INSERM, EFS BFC, UMR1098, RIGHT, University of Bourgogne Franche-Comté, Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, F-25000 Besançon, France.\', \'Department of Medical Oncology, Biotechnology and Immuno-Oncology Platform, University Hospital of Besançon, F-25000 Besançon, France; INSERM, EFS BFC, UMR1098, RIGHT, University of Bourgogne Franche-Comté, Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, F-25000 Besançon, France; Department of Medical Oncology, University Hospital of Besançon, F-25000 Besançon, France.\', \'Anesthesia and Intensive Care Unit, University Hospital of Besançon, F-25000 Besançon, France; Medical Intensive Care Unit, University Hospital of Besançon, F-25000 Besançon, France.\', \'Department of Medical Oncology, Biotechnology and Immuno-Oncology Platform, University Hospital of Besançon, F-25000 Besançon, France.\', \'INSERM, EFS BFC, UMR1098, RIGHT, University of Bourgogne Franche-Comté, Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, F-25000 Besançon, France; Department of Chest Disease, University Hospital of Besançon, F-25000 Besançon, France.\', \'Anesthesia and Intensive Care Unit, University Hospital of Besançon, F-25000 Besançon, France; Research Unit EA3920, Université de Franche Comté, F-25000 Besançon, France.\', \'Medical Intensive Care Unit, University Hospital of Besançon, F-25000 Besançon, France; Research Unit EA3920, Université de Franche Comté, F-25000 Besançon, France; Australian and New Zealand Intensive Care Research Center, Department of Epidemiology and Preventive Medicine, Monash University, Australia.\', \'Department of Virology, University Hospital of Besançon, F-25000 Besançon, France; Research Unit EA3181, Université de Franche Comté, F-25000 Besançon, France.\', \'INSERM, EFS BFC, UMR1098, RIGHT, University of Bourgogne Franche-Comté, Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, F-25000 Besançon, France; Department of Medical Oncology, University Hospital of Besançon, F-25000 Besançon, France.\', \'Department of Pharmacy, University Hospital of Besançon, F-25000 Besançon, France.\', \'Department of Pharmacy, University Hospital of Besançon, F-25000 Besançon, France; INSERM, EFS BFC, UMR1098, RIGHT, University of Bourgogne Franche-Comté, Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, F-25000 Besançon, France.\', \'Department of Infectious Disease, University Hospital of Besançon, F-25000 Besançon, France.\', \'Department of Infectious Disease, University Hospital of Besançon, F-25000 Besançon, France; UMR-CNRS 6249 Chrono-Environnement, Université Bourgogne Franche-Comté, F-25000 Besançon, France.\', \'Department of Infectious Disease, University Hospital of Besançon, F-25000 Besançon, France; UMR-CNRS 6249 Chrono-Environnement, Université Bourgogne Franche-Comté, F-25000 Besançon, France. Electronic address: kbouiller@chu-besancon.fr.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Bohard_Louis> <https://research.tib.eu/covid-19/entity/Borg_Christophe> <https://research.tib.eu/covid-19/entity/Bouard_Adeline> <https://research.tib.eu/covid-19/entity/Bouiller_Kevin> <https://research.tib.eu/covid-19/entity/Capellier_Gilles> <https://research.tib.eu/covid-19/entity/Chirouze_Catherine> <https://research.tib.eu/covid-19/entity/Clairet_Anne-Laure> <https://research.tib.eu/covid-19/entity/Dubois_Maxime> <https://research.tib.eu/covid-19/entity/Eberst_Guillaume> <https://research.tib.eu/covid-19/entity/Kroemer_Marie> <https://research.tib.eu/covid-19/entity/Lepiller_Quentin> <https://research.tib.eu/covid-19/entity/Limat_Samuel> <https://research.tib.eu/covid-19/entity/Malinowski_L%C3%A9a> <https://research.tib.eu/covid-19/entity/Mansi_Laura> <https://research.tib.eu/covid-19/entity/Orillard_Emeline> <https://research.tib.eu/covid-19/entity/Pili_Floury_Sebastien> <https://research.tib.eu/covid-19/entity/Spehner_Laurie> <https://research.tib.eu/covid-19/entity/Vettoretti_Lucie> <https://research.tib.eu/covid-19/entity/Westeel_Virginie>
?:doi	<https://research.tib.eu/covid-19/entity/S0163-4453%2820%2930563-610.1016/j.jinf.2020.08.036>
?:doi	S0163-4453(20)30563-610.1016/j.jinf.2020.08.036
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Comment> <https://research.tib.eu/covid-19/entity/Letter>
?:journal	The Journal of infection
is ?:pmid of	<https://research.tib.eu/covid-19/entity/32853599>
?:pmid	<https://research.tib.eu/covid-19/entity/32853599>
?:pmid	32853599
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	-1.0
?:rankingScore_hIndex	-1
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/C0678209_PROCESS_OF_C0030705>
?:title	COVID-19 patients display distinct SARS-CoV-2 specific T-cell responses according to disease severity.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2021

Property

Value

is ?:annotates of

?:authorAffiliation

[\'Department of Medical Oncology, Biotechnology and Immuno-Oncology Platform, University Hospital of Besançon, F-25000 Besançon, France; Department of Pharmacy, University Hospital of Besançon, F-25000 Besançon, France; INSERM, EFS BFC, UMR1098, RIGHT, University of Bourgogne Franche-Comté, Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, F-25000 Besançon, France.\', \'Department of Medical Oncology, Biotechnology and Immuno-Oncology Platform, University Hospital of Besançon, F-25000 Besançon, France; INSERM, EFS BFC, UMR1098, RIGHT, University of Bourgogne Franche-Comté, Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, F-25000 Besançon, France; Department of Medical Oncology, University Hospital of Besançon, F-25000 Besançon, France.\', \'Anesthesia and Intensive Care Unit, University Hospital of Besançon, F-25000 Besançon, France; Medical Intensive Care Unit, University Hospital of Besançon, F-25000 Besançon, France.\', \'Department of Medical Oncology, Biotechnology and Immuno-Oncology Platform, University Hospital of Besançon, F-25000 Besançon, France.\', \'INSERM, EFS BFC, UMR1098, RIGHT, University of Bourgogne Franche-Comté, Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, F-25000 Besançon, France; Department of Chest Disease, University Hospital of Besançon, F-25000 Besançon, France.\', \'Anesthesia and Intensive Care Unit, University Hospital of Besançon, F-25000 Besançon, France; Research Unit EA3920, Université de Franche Comté, F-25000 Besançon, France.\', \'Medical Intensive Care Unit, University Hospital of Besançon, F-25000 Besançon, France; Research Unit EA3920, Université de Franche Comté, F-25000 Besançon, France; Australian and New Zealand Intensive Care Research Center, Department of Epidemiology and Preventive Medicine, Monash University, Australia.\', \'Department of Virology, University Hospital of Besançon, F-25000 Besançon, France; Research Unit EA3181, Université de Franche Comté, F-25000 Besançon, France.\', \'INSERM, EFS BFC, UMR1098, RIGHT, University of Bourgogne Franche-Comté, Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, F-25000 Besançon, France; Department of Medical Oncology, University Hospital of Besançon, F-25000 Besançon, France.\', \'Department of Pharmacy, University Hospital of Besançon, F-25000 Besançon, France.\', \'Department of Pharmacy, University Hospital of Besançon, F-25000 Besançon, France; INSERM, EFS BFC, UMR1098, RIGHT, University of Bourgogne Franche-Comté, Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, F-25000 Besançon, France.\', \'Department of Infectious Disease, University Hospital of Besançon, F-25000 Besançon, France.\', \'Department of Infectious Disease, University Hospital of Besançon, F-25000 Besançon, France; UMR-CNRS 6249 Chrono-Environnement, Université Bourgogne Franche-Comté, F-25000 Besançon, France.\', \'Department of Infectious Disease, University Hospital of Besançon, F-25000 Besançon, France; UMR-CNRS 6249 Chrono-Environnement, Université Bourgogne Franche-Comté, F-25000 Besançon, France. Electronic address: kbouiller@chu-besancon.fr.\']

?:citedBy